-
Mashup Score: 1New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic - 3 year(s) ago
TO THE EDITOR:Section:IntroductionWe previously reported a substantial decline in new cancer diagnoses early in the COVID-19 pandemic in the United States,1 with a subsequent rebound that did not reach prepandemic levels.2 This study updates the analysis for April 2021 through March 2022.MethodsThis cross-sectional study included patients across the United States who received testing at Quest…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular profiling (MP) that could increase the number of patients benefiting from targeted therapy. We implemented an integrated clinical genomics program (CGP), including a virtual Molecular Tumor Board (MTB), and…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients [Jul 15, 2022] Farhangfar et al. @JCOCCI_ASCO https://t.co/HjXFvVMyXv #PrecisionMedicine #CancerDisparities
-
-
Mashup Score: 2Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities - 3 year(s) ago
Twitter use has increased among patients with cancer, advocates, and oncology professionals. Hashtags, a form of metadata, can be used to share content, organize health information, and create virtual communities of interest. Cancer-specific hashtags modeled on a breast cancer community, #bcsm, led to the development of a structured set of hashtags called the cancer tag ontology. In this article,…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Organizing Online Health Content: Developing Hashtag Collections... [6/28/19] - @subatomicdoc @pfanderson @mtmdphd @TheLizArmy @JFreemanDaily @audvin @drdonsdizon @CBlotner_ @DavidCookeMD @womenofteal @stales @fischmd @colleen_young @DrAttai @JCOCCI_ASCO https://t.co/776r7qmxcY https://t.co/Pk7LHmEKmu
-
-
Mashup Score: 0
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular profiling (MP) that could increase the number of patients benefiting from targeted therapy. We implemented an integrated clinical genomics program (CGP), including a virtual Molecular Tumor Board (MTB), and…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients [Jul 15, 2022] Farhangfar et al. @JCOCCI_ASCO https://t.co/HjXFvVuY5X #PrecisionMedicine #CancerDisparities https://t.co/1080ZvblM3
-
-
Mashup Score: 6Leveraging an Informatics Approach to Identify an Unmet Clinical Need for BRCA1/2 Testing Among Patients With Ovarian Cancer - 3 year(s) ago
PURPOSE Although BRCA1/2 testing in ovarian cancer improves outcomes, it is vastly underutilized. Scalable approaches are urgently needed to improve genomically guided care. METHODS We developed a Natural Language Processing (NLP) pipeline to extract electronic medical record information to identify recipients of BRCA testing. We applied the NLP pipeline to assess testing status in 308 patients…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
1/ Genetic testing should be a core element of care for all patients with #ovariancancer. However, nationally, only ~30% of women are tested. We developed & applied an NLP algorithm to EHR data to rapidly identify women who need testing. https://t.co/0JGGuryl6c https://t.co/HZ2mQ3rOPO
-
-
Mashup Score: 0Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities - 3 year(s) ago
Twitter use has increased among patients with cancer, advocates, and oncology professionals. Hashtags, a form of metadata, can be used to share content, organize health information, and create virtual communities of interest. Cancer-specific hashtags modeled on a breast cancer community, #bcsm, led to the development of a structured set of hashtags called the cancer tag ontology. In this article,…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Organizing Online Health Content: Developing Hashtag Collections... [6/28/19] - @subatomicdoc @pfanderson @mtmdphd @TheLizArmy @JFreemanDaily @audvin @drdonsdizon @CBlotner_ @DavidCookeMD @womenofteal @stales @fischmd @colleen_young @DrAttai @JCOCCI_ASCO https://t.co/776r7qmxcY https://t.co/7zXSatrdfh
-
-
Mashup Score: 0Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities - 3 year(s) ago
Twitter use has increased among patients with cancer, advocates, and oncology professionals. Hashtags, a form of metadata, can be used to share content, organize health information, and create virtual communities of interest. Cancer-specific hashtags modeled on a breast cancer community, #bcsm, led to the development of a structured set of hashtags called the cancer tag ontology. In this article,…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Organizing Online Health Content: Developing Hashtag Collections... [6/28/19] - @subatomicdoc @pfanderson @mtmdphd @TheLizArmy @JFreemanDaily @audvin @drdonsdizon @CBlotner_ @DavidCookeMD @womenofteal @stales @fischmd @colleen_young @DrAttai @JCOCCI_ASCO https://t.co/776r7qmxcY https://t.co/pyiyLg8sHJ
-
-
Mashup Score: 0
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular profiling (MP) that could increase the number of patients benefiting from targeted therapy. We implemented an integrated clinical genomics program (CGP), including a virtual Molecular Tumor Board (MTB), and…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients [Jul 15, 2022] Farhangfar et al. @JCOCCI_ASCO https://t.co/HjXFvVuY5X #PrecisionMedicine #CancerDisparities
-
-
Mashup Score: 0
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular profiling (MP) that could increase the number of patients benefiting from targeted therapy. We implemented an integrated clinical genomics program (CGP), including a virtual Molecular Tumor Board (MTB), and…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Oncs, Latest HeadlinesTweet-
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients [Jul 15, 2022] Farhangfar et al. @JCOCCI_ASCO https://t.co/HjXFvVuY5X #PrecisionMedicine #CancerDisparities
-
-
Mashup Score: 1Decision Support Systems in Oncology - 3 year(s) ago
Precision medicine is the future of health care: please watch the animation at https://vimeo.com/241154708. As a technology-intensive and -dependent medical discipline, oncology will be at the vanguard of this impending change. However, to bring about precision medicine, a fundamental conundrum must be solved: Human cognitive capacity, typically constrained to five variables for decision making…
Source: JCO Clinical Cancer InformaticsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @JCOCCI_ASCO: 🔥 Check out what’s hot this week in #JCOCCI: 💻 Decision Support Systems in Oncology 👉 https://t.co/zLzpR066vL #healthAI #…
-
RT @JCOCCI_ASCO: Read the full article here ➡️ https://t.co/z9rwoYqQLQ #COVID19nCancer